RXO, Inc.
NYSE:RXOTrucking
+$0.80 today
- Market cap
- $4.72B
- Beta
- 1.97
- P/E (TTM)
- -41.3
- EPS (TTM)
- -$0.62
Volume 3.64M
Average 2.33M
RXO Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
RXO, Inc.NYSE: RXO
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables turns negative
Q2 FY2026 accounts receivables was -$231K, compared with $83M a year earlier. Trailing-twelve-month accounts receivables was -$156.23M.
Context
- Accounts receivables amounted to 0.1% of revenue in FY2025, down 2.3 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near -$231K or moves back toward the trailing-twelve-month quarterly average of -$39.06M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (5M) USD
- Year-over-year change
- +95.4%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (5M) | +95.4% |
| FY2024 | 2024-12-31 | (109M) | -169.0% |
| FY2023 | 2023-12-31 | 158M | +71.7% |
| FY2022 | 2022-12-31 | 92M | +138.0% |
| FY2021 | 2021-12-31 | (242M) | — |
Accounts Receivables vs competitors
How RXO compares with its peers on the latest reported figures
- RXO's LTM Jun 2026 accounts receivables of $156.23M is the largest of the 11 companies compared; the peer median is $17.67M.
- Its year-over-year change of -522.2% is the lowest of 11, against a peer median of -1.3%.
- Accounts receivables amounts to 2.6% of revenue for RXO, versus a peer median of 2.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $156.23M | -522.2% | — | 2.6% | |
| LTM Jun 2026 | $150.59M | -194.8% | -60.7% | 5.6% | |
TICTIC Solutions, Inc. | LTM Jun 2026 | $93.1M | +227.4% | — | 4.5% |
| LTM Jun 2026 | $79.6M | +133.6% | +2.3% | 4.0% | |
| LTM Jun 2026 | $46.6M | -345.3% | -45.2% | 1.3% | |
| LTM Jul 2026 | $35.3M | -79.4% | -8.6% | 0.4% | |
| LTM Mar 2026 | $25.01M | +170.9% | +252.7% | 27.7% | |
| LTM Jun 2026 | $12.15M | +178.1% | -13.7% | 0.4% | |
| LTM Sep 2026 | $10.34M | -126.4% | — | 1.5% | |
| LTM Jun 2026 | $7.54M | -58.7% | -23.1% | 0.8% | |
| LTM Mar 2026 | $2.33M | +56.0% | — | 21.4% | |
| Peer median (excluding RXO) | $17.67M | -1.3% | -13.7% | 2.7% | |
Competitors are the stored peer set for RXO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
RXO, Inc.
NYSE:RXO
Intrinsic Alpha fair value
Locked
Current Price
$28.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.